ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,202Medicare Part D Prescriptions Filled, Including Refills

Rank: 158 out of 1121

$855K Total Retail Price of All Prescriptions

Rank: 119 out of 1121

588 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 588 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 588 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 12,838 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
SIMVASTATIN 563 525 1 1
LEVOTHYROXINE SODIUM 522 477 2 2
POTASSIUM CHLORIDE 465 438 3 12
LISINOPRIL 385 367 4 4
AMLODIPINE BESYLATE 322 286 5 5
TRAMADOL HCL 285 234 6 25
WARFARIN SODIUM 275 267 7 11
OMEPRAZOLE 255 212 8 6
METFORMIN HCL 240 188 9 8
HYDROCODONE-ACETAMINOPHEN 233 215 S3 10 3
ATORVASTATIN CALCIUM 232 198 11 15
FUROSEMIDE 221 221 12 7
PRAVASTATIN SODIUM 221 199 12 14
METOPROLOL SUCCINATE 216 209 14 23
NAMENDA 211 211 15 53
METOPROLOL TARTRATE 206 195 16 9
ALENDRONATE SODIUM 198 186 17 37
QUETIAPINE FUMARATE 184 174 18 75
METFORMIN HCL ER 183 178 19 47
DONEPEZIL HCL 176 173 20 35
LOSARTAN POTASSIUM 172 167 21 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 150 144 22 31
HYDROCHLOROTHIAZIDE 146 141 23 10
CITALOPRAM HBR 146 132 23 18
RANITIDINE HCL 128 121 25 33
CRESTOR 127 96 26 28
TAMSULOSIN HCL 126 122 27 32
DOXAZOSIN MESYLATE 123 110 28 93
MIRTAZAPINE 117 115 29 56
PAROXETINE HCL 114 68 30 58
SERTRALINE HCL 114 108 30 21
GABAPENTIN 113 94 32 13
NEXIUM 112 93 33 24
ZETIA 111 100 34 80
CLONIDINE HCL 109 104 35 39
ALLOPURINOL 106 99 36 30
ATENOLOL 97 83 37 16
NOVOLIN 70-30 93 89 38 235
CARVEDILOL 93 91 38 20
MELOXICAM 88 76 40 22
PANTOPRAZOLE SODIUM 87 81 41 29
CLOPIDOGREL 86 85 42 27
SEROQUEL 85 78 43 134
ZOLPIDEM TARTRATE 84 72 44 19
LOVASTATIN 83 70 45 26
SPIRONOLACTONE 82 82 46 54
ADVAIR DISKUS 82 79 46 64
AZITHROMYCIN 81 63 48 44
FLUTICASONE PROPIONATE 76 57 49 36
HYDRALAZINE HCL 71 69 50 66
PREDNISONE 71 68 50 43
TRAZODONE HCL 68 67 52 40
GLIPIZIDE 68 56 52 84
DIOVAN 66 66 54 45
TERAZOSIN HCL 65 65 55 130
AMITRIPTYLINE HCL 65 65 R 55 61
SPIRIVA 64 61 57 49
JANUVIA 63 50 58 81
NITROGLYCERIN PATCH 62 61 59 198
TRIAMTERENE-HCTZ 62 60 59 38
BENAZEPRIL HCL 61 54 61 41
BISOPROLOL-HYDROCHLOROTHIAZIDE 61 57 61 179
ENALAPRIL MALEATE 59 49 63 73
DIGOXIN 59 59 63 59
LOSARTAN-HYDROCHLOROTHIAZIDE 58 49 65 46
VENLAFAXINE HCL 57 57 66 201
PLAVIX 57 57 66 42
CIPROFLOXACIN HCL 57 51 66 57
TESTOSTERONE CYPIONATE 57 50 S3 66 393
DIVALPROEX SODIUM 56 55 70 98
LANTUS 54 35 71 52
DOXYCYCLINE HYCLATE 54 50 71 103
GLIPIZIDE ER 54 27 71 142
BUMETANIDE 53 53 74 152
NIASPAN 53 48 74 166
CARBIDOPA-LEVODOPA 52 51 76 118
FLUOXETINE HCL 50 23 77 60
LANTUS SOLOSTAR 50 41 77 109
PREMARIN 50 36 R 77 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 7, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.